Structural and energetic modulation of the raloxifene-STAT3 complex by metformin and cisplatin: implications for disrupting STAT3 signaling
{{output}}
Raloxifene, a selective estrogen receptor modulator, has shown potential as an inhibitor of the STAT3 signaling pathway, which is frequently dysregulated in cancer and inflammatory diseases. In this study, molecular docking and molecular dynamics (MD) simulati... ...
